問卷

TPIDB > Search Result

Search Result

篩選

List

275Cases

2017-06-01 - 2026-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Terminated5Sites

2018-01-15 - 2029-06-30

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting4Sites

2018-10-01 - 2031-09-01

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting5Sites

陳訓徹
Linkou Chang Gung Medical Foundation

Division of General Surgery

2017-06-01 - 2024-04-08

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Terminated9Sites

2016-12-15 - 2020-06-08

Phase III

Not yet recruiting
A Phase III, Randomized, Open-label Clinical Trial of Pembrolizumab (MK-3475) versus Paclitaxel in Asian Subjects with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma who Progressed after First-Line Therapy with Platinum and Fluoropyrimidine
  • Condition/Disease

    Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

  • Test Drug

    Keytruda

Participate Sites
5Sites

Terminated3Sites

Study ended1Sites

2017-05-10 - 2025-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated3Sites

2019-08-09 - 2026-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting3Sites

2017-01-22 - 2023-12-22

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Terminated5Sites

2016-03-16 - 2023-04-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Suspended4Sites

2017-03-15 - 2024-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated6Sites